Moradzadeh Khiavi Monir, Anvari Enayat, Hamishehkar Hamed, Abdal Khadijeh
Department of Oral and Maxillofacial Pathology, Faculty of Dentistry, Tehran University of Medical Sciences, Tehran, Iran.
Department of Physiology, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran.
Asian Pac J Cancer Prev. 2019 Jul 1;20(7):1973-1977. doi: 10.31557/APJCP.2019.20.7.1973.
Purpose: Oral squamous cell carcinoma (OSCC) is the most common and most malignant disorder of the oral cavity. Standard cancer treatments have many complications for patients. Nausea, vomiting, and perturbation in blood cells are the most common side effects when using Doxorubicin (Dox) for the treatment of OSCC. Use of Doxorubicin-loaded nano-particles (n-Dox) give rise to increase its biological efficacy and the rapeutic effects. This study assessed the efficacy of the injectable form of the n-Doxon blood parameters and cardiac and liver enzymes compared to the commercial form of Dox in OSCC-induced by 4NQO in rats. Methods: 4-nitroquinoline-1-oxideas was used as a solution in drinking water for inducing OSCC during 14 weeks in male Sprague-Dawley rats. Four groups of animals were categorized randomly: first (OSCC+Dox), second (OSCC+n-Dox), third (OSCC) and, last, healthy animals. Results: Using n-Dox had no harmful effect on the number of white and red blood cells. Thrombocytopenia and leukopenia in animals treated with n-Dox was less than the other groups. Hemoglobin and hematocrit in all treated groups did not differ and were similar to the healthy control. Hepatic and cardiac enzymes did not show any significant difference in any of the groups. Conclusion: The results of this research showed that significant decreases in haematological changes occurred, including leukopenia and anemia, in an animal model of OSCC induced by 4-NQO following use of n-Dox with compare to Dox. Use of n-Dox is better than of Dox for treatment of OSCC.
口腔鳞状细胞癌(OSCC)是口腔最常见且恶性程度最高的疾病。标准癌症治疗方法给患者带来许多并发症。使用阿霉素(Dox)治疗OSCC时,恶心、呕吐和血细胞紊乱是最常见的副作用。使用载有阿霉素的纳米颗粒(n-Dox)可提高其生物学功效和治疗效果。本研究评估了与市售形式的Dox相比,注射用n-Dox对4NQO诱导的大鼠OSCC血液参数、心脏和肝脏酶的疗效。方法:将4-硝基喹啉-1-氧化物作为溶液加入雄性Sprague-Dawley大鼠的饮用水中,持续14周以诱导OSCC。将四组动物随机分类:第一组(OSCC+Dox)、第二组(OSCC+n-Dox)、第三组(OSCC)以及最后一组健康动物。结果:使用n-Dox对白细胞和红细胞数量没有有害影响。用n-Dox治疗的动物血小板减少症和白细胞减少症比其他组少。所有治疗组的血红蛋白和血细胞比容没有差异,与健康对照组相似。所有组的肝酶和心肌酶均未显示出任何显著差异。结论:本研究结果表明,与Dox相比,在4-NQO诱导的OSCC动物模型中,使用n-Dox后血液学变化显著降低,包括白细胞减少症和贫血。使用n-Dox治疗OSCC比使用Dox更好。